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Introduction
Kawasaki disease (KD) is an acute, self-limited febrile ill-
ness that mainly affecting small- to medium-sized ves-
sels and occurs in early childhood. The etiology is
currently unknown, however it likely results from an
immunologic response triggered by microbial agents,
with documented genetic susceptibility. Intravenous
administration of immunoglobulin (IVIG) is the gold
standard therapy for coronary arteritis in the acute
phase of KD; some patients do not respond to IVIG and
coronary aneurysms continue to develop in 5%. The
most serious complications are coronary vasculitis and
aneurysms. 15% of these patients do not respond to
IVIG (Refractory KD:RMK) and have a higher risk of
aneurysms.
Objectives
To predict RKD, Kobayashi et al. suggested a score sys-
tem including: age, gender, days of the disease at IVIG
start, neutrophyls and platelets count, AST, CRP, Na.
Recent reports suggest the utility of a combined treat-
ment with IVIG and steroids or Infliximab to reduce the
risk of coronary involvement in RKD. We analyzed
Kobayashi criteria and we also considered D-dimer and
gamma-GT, to elevate the sensitivity of the score.
Methods
We analyzed the clinical records of the Paediatric Clinic
of Palermo, since January 2008 till april 2014: 65
patients with KD (68% Typical KD: TKD; 4% Atypical
KD: AKD; 28% incomplete KD: IKD).
Results
33 (51%) are males; 32 (49%) females, with a M:F ratio of
1.03, lower of that reported (1.5-1.7). Age at the diagnosis
was 2.1±1.8 years. The fever at the admittance was since
5.39±2.40 days; the most frequently relieved symptoms
were: conjunctivitis (88%), stomatitis (85%), rash (71%).
IVIG were administered 6.7±2.5 days later the fever start.
Defervescence occurred 36.8±24 hours after IGEV. 53
patients (82%) received 1 dose of IVIG; 18% had a RKD,
with persistent fever after IVIG. 11% responded to the
second dose; 5% to three doses; one patient to Infliximab.
15 patients (23%) had aneurisms (20% in responders; 36%
in RKD). 64% (7/11) of RKD vs 44% (24/54) of respon-
ders showed cardiac involvement. Precocious pericarditis
was associated with and more precocious than coronary
involvement.
Age was lower in RWD (1.4±1.1). The days of fever
pre-IVIG were inversely correlated with IVIG doses. 5/11
(45%) of RKD received the first dose <5days. None had
platelet count <30.000 mm3 or % neutrophils >80%. 2
had AST>100. 82% (9/11) of RKD had Na<133 vs 26% of
responders. Leucocytes were significantly directly corre-
lated with fibrinogen pre-IVIG (p:0.001). IVIG doses
were directly correlated with CRP post-IVIG (p:0.044),
gamma-GT pre-IGEV (p:0.008), D-dimer pre-IGEV
(p:0.014). In RKD D-dimer was 1188±724 ng/ml, signifi-
catly higher than in respoders (798±662).
Days of fever at the recovery were inversely correlated
with pre-IVIG AST (p:0.034), and ALT (p:0.013).
Conclusion
Our data well correlate with Kobayashi score. However we
stress the role of D-dimer and gamma-GT as prognosic
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